A Randomized, Double-Blind Tolerability Trial of Cannabinoids for Symptom Management in Children with Cancer: the CAN-PONC Trial
We received a No Objection Letter from Health Canada and is currently undergoing ethics reviews at study sites.
This study is funded by Canadian Institutes of Health Research (CIHR) and the Canadian Cancer Society (CCS).
This study is registered with ClinicalTrials.gov, NCT05754840.